Feasibility Randomised Control Trial of OptiMal: A Self-Management Intervention for Cancer Survivors.
Lauren BolandKathleen E BennettSinead CuffeCliona GrantM John KennedyDeirdre ConnollyPublished in: Current oncology (Toronto, Ont.) (2023)
Recruitment and retention in this study was similar to other cancer trials and the high adherence rate indicates that OptiMal is an acceptable self-management intervention for cancer survivors and warrants further investigation. OptiMal is intended to address symptoms reported across different cancer types. However, a limitation of this study was that the majority of participants had breast cancer, and therefore, generalisability of findings cannot be assumed for other cancer types. Future studies of OptiMal therefore need to use different strategies to recruit survivors of other cancer types.